| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0045 | 0.9 |